Opioid use disorder (OUD) is a global health crisis, affecting over 16 million people and contributing to approximately 120,000 deaths annually. Driven by the prolonged use of opioids like morphine, OUD leads to severe withdrawal symptoms, intense cravings, and increased tolerance, ultimately creating an overwhelming cycle of dependency. Morphine, a major opium alkaloid, induces euphoria, analgesia, and anxiolysis, which, while initially pleasurable, contributes to its high potential for substance use disorder (SUD). Dependence on morphine presents a formidable clinical challenge, often resulting in relapse and posing considerable harm to individuals, families, and society. Existing treatments are often limited in effectiveness and carry potential side effects, underscoring an urgent need for novel and safer therapeutic approaches. Our research explores the potential of complementary and alternative medicine (CAM) in addressing OUD by focusing on the therapeutic properties of Delphinium denudatum and Myristica fragrans (nutmeg). Ethanol extracts and key phytochemicals from these plants, including trimyristin, eugenol, and myristicin from Myristica fragrans, and methyllcaconitine from Delphinium denudatum, are being investigated for their capacity to modulate addiction-related pathways. Preliminary findings suggest that these compounds may alleviate withdrawal symptoms, reduce cravings, and influence neurotransmitter systems implicated in morphine dependency. Our ongoing research continues to isolate and characterize these bioactive compounds, aiming to bridge critical gaps in current OUD treatment options. Additionally, our lab is actively investigating other medicinal plants and their phytochemicals to broaden the therapeutic arsenal against opioid addiction. By pursuing multi-targeted, plant-based interventions, we hope to contribute to the development of safer, more effective strategies that mitigate the devastating impact of morphine addiction on individuals and society.
December 28, 2025